<code id='B84B92209D'></code><style id='B84B92209D'></style>
    • <acronym id='B84B92209D'></acronym>
      <center id='B84B92209D'><center id='B84B92209D'><tfoot id='B84B92209D'></tfoot></center><abbr id='B84B92209D'><dir id='B84B92209D'><tfoot id='B84B92209D'></tfoot><noframes id='B84B92209D'>

    • <optgroup id='B84B92209D'><strike id='B84B92209D'><sup id='B84B92209D'></sup></strike><code id='B84B92209D'></code></optgroup>
        1. <b id='B84B92209D'><label id='B84B92209D'><select id='B84B92209D'><dt id='B84B92209D'><span id='B84B92209D'></span></dt></select></label></b><u id='B84B92209D'></u>
          <i id='B84B92209D'><strike id='B84B92209D'><tt id='B84B92209D'><pre id='B84B92209D'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:33497
          Colorful one hundred dollar bills -- health tech coverage from STAT
          Adobe

          Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

          At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

          advertisement

          Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Finland to offer bird flu vaccine to select groups of people, a possible global first
          Finland to offer bird flu vaccine to select groups of people, a possible global first

          H5N1birdfluparticlesCDCandNIAIDLONDON—Finlandispreparingtooffervaccinestopeopleatriskofexposuretoana

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          FDA approves Moderna’s RSV vaccine, its second licensed product

          TheFDAhasapprovedModerna’sRSVvaccineforolderadults.ModernaTheFoodandDrugAdministrationonFridayapprov